Why we need easy access to all data from all clinical trials and how to accomplish it
Open Access
- 23 November 2011
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Trials
- Vol. 12 (1), 249
- https://doi.org/10.1186/1745-6215-12-249
Abstract
International calls for registering all trials involving humans and for sharing the results, and sometimes also the raw data and the trial protocols, have increased in recent years. Such calls have come, for example, from the Organization for Economic Cooperation and Development (OECD), the World Health Organization (WHO), the US National Institutes of Heath, the US Congress, the European Commission, the European ombudsman, journal editors, The Cochrane Collaboration, and several funders, for example the UK Medical Research Council, the Wellcome Trust, the Bill and Melinda Gates Foundation and the Hewlett Foundation.This publication has 87 references indexed in Scilit:
- Dendritic cells take on more tasks in the liver?Hepatology, 2011
- Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trialsBMJ, 2010
- Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewersBMJ, 2010
- Avoidable waste in the production and reporting of research evidenceThe Lancet, 2009
- Globalized Clinical Trials and Informed ConsentNew England Journal of Medicine, 2009
- Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and PresentationPLoS Medicine, 2008
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyNew England Journal of Medicine, 2008
- Clinical trial registrationBMJ, 2007
- Did regulators fail over selective serotonin reuptake inhibitors?BMJ, 2006
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsPublished by American Medical Association (AMA) ,2004